The awards, held at the Grosvenor Hotel in London, were emotive’s first outing under their new brand identity. MyAsthma was a finalist in two categories and won the prestigious Excellence in Patient Programmes award.
Lead judge, Neil Flash, said, “MyAsthma by GSK was a clear winner in this category. Putting patients at the centre, and through an innovative use of technology, it afforded patients in a difficult-to-reach age population an opportunity to collect information about their condition and use it in an on-going dialogue with their physicians to improve the control of their asthma.”
MyAsthma is a multi-platform app that allows people with asthma to monitor their condition and receive personalised information and alerts. Since launch, over 6,000 patients have registered on to the MyAsthma programme and it is currently in the process of rolling out to a further 8 markets.
Chris Edmonds, Managing Director of emotive commented, “I’m delighted that MyAsthma has received such high accolade with this communiqué award. It was a privilege for us to work with GSK on a truly revolutionary digital programme.”
Paul Reynolds from GSK remarked, “emotive have remained passionately and personally involved in this project from the outset, which cannot be said for many agencies. MyAsthma is making a small but profound change to asthma management, and it delivers health outcome improvements. There are many apps being designed and built to please marketing teams and their managers, but MyAsthma is different. It was never a vanity project, but something that we built from customer insight and need.”